Noninvasive Brain Stimulation for Stroke Improvement
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Stroke
- Sponsor
- University Hospital of Mont-Godinne
- Enrollment
- 200
- Locations
- 1
- Primary Endpoint
- change in function before/after tDCS
- Status
- Suspended
- Last Updated
- 2 years ago
Overview
Brief Summary
Noninvasive brain stimulations will be used in acute and chronic stroke patients to improve a variety of functions.
Detailed Description
Noninvasive brain stimulations (NIBS) will be used in acute and chronic stroke patients to improve a variety of functions such as motor functions, cognitive functions, ... NIBS will be applied in a placebo-controlled, double-blind, randomised fashion. Behavioural data will be collected before and after NIBS, as well as brain functional imaging data.
Investigators
Pr Yves Vandermeeren, MD, PhD
Professor, MD, PhD
University Hospital of Mont-Godinne
Eligibility Criteria
Inclusion Criteria
- •stroke with at least slight deficit
Exclusion Criteria
- •contraindication to tDCS and/or to fMRI
- •presence of metal in the head
- •unability to understand / complete behavioural tasks
- •chronic intake of alcohol or recreative drugs
- •major health condition
- •presence of pacemaker
- •pregnancy
Outcomes
Primary Outcomes
change in function before/after tDCS
Time Frame: Before intervention, immediately after intervention, 10-20-30-40-50-60 min after intervention; long-term after intervention : 1-2-3-4 weeks, 2-3-4-5-6-7-8-9-10-11-12 months
any brain function impaired by stroke
Secondary Outcomes
- change in neuroimaging and neurophysiological before/after tDCS(Before intervention, immediately after intervention, 10-20-30-40-50-60 min after intervention; long-term after intervention : 1-2-3-4 weeks, 2-3-4-5-6-7-8-9-10-11-12 months)